Skip to main content

Table 4 Basic demographic data of patients with hepatocellular carcinoma of different BCLC stages between surgical resection and non-surgical resection after propensity score matching

From: Surgical resection significantly promotes the overall survival of patients with hepatocellular carcinoma: a propensity score matching analysis

Variable

BCLC stage 0 (N = 43)

BCLC stage A (N = 578)

BCLC stage B (N = 327)

BCLC stage C (N = 116)

SR

(N = 27)

Non-SR (N = 18)

P value

SR

(N = 289)

Non-SR

(N = 289)

P value

SR

(N = 164)

Non-SR (N = 163)

P value

SR

(N = 58)

Non-SR

(N = 58)

P value

Male

21 (77.8)

13 (72.2)

0.671

208 (72)

197 (68.2)

0.318

135 (82.3)

137 (84)

0.675

45 (77.6)

48 (82.8)

0.485

Age (years)

55 (23–83)

59 (24–85)

0.312

62 (29–90)

60 (28–92)

0.066

61 (30–88)

62 (30–91)

0.346

60 (25–87)

60 (19–99)

0.910

Smoking

10 (37)

10 (55.6)

0.221

114 (39.4)

95 (32.9)

0.128

71 (43.3)

57 (35.0)

0.123

20 (34.5)

16 (27.5)

0.151

Alcohol use

8 (29.8)

7 (38.9)

0.519

96 (33.2)

86 (29.8)

0.371

67 (40.9)

62 (38.0)

0.602

17 (29.3)

13 (22.4)

0.283

HBV positive

25 (92.6)

12 (66.7)

0.260

200 (69.2)

200 (69.2)

1.000

111 (67.7)

108 (66.3)

0.784

41 (70.7)

36 (62.1)

0.085

HCV positive

6 (22.2)

5 (27.5)

0.671

89 (30.8)

76 (26.3)

0.231

41 (25.0)

44 (27.0)

0.681

18 (31.0)

11 (19.0)

0.133

Cirrhosis

20 (74.1)

13 (72.2)

0.891

177 (61.2)

168 (58.1)

0.445

95 (57.9)

80 (49.1)

0.109

28 (48.3)

27 (46.5)

0.873

Child–Pugh class A

20 (74.1)

13 (72.2)

0.891

87 (30.1)

92 (31.8)

0.819

60 (36.6)

68 (41.7)

0.198

20 (34.5)

18 (31.0)

0.796

Tumor size (cm)

1.7 (1.0–2.0)

1.6 (1.0–2.0)

0.812

2.8 (1.0–5.0)

2.7 (1.0–5.0)

0.289

7.7 (1.2–21)

7.5 (1.2–21)

0.105

9.5 (1.2–27)

9.4 (1.2–27)

0.885

Tumor number

1 (1–1)

1 (1–1)

1.000

1.4 (1–3)

1.5 (1–3)

0.227

2.3 (1–5)

2.5 (1–11)

0.077

2.7 (1–11)

2.7 (1–11)

0.903

Mortality

15 (55.6)

12 (66.7)

0.456

155 (53.6)

183 (63.3)

0.018

95 (57.9)

103 (63.2)

0.33

28 (48.3)

55 (94.8)

0.0001

Median OS (months)

70 (30–96)

43 (11–81)

 

53 (3–88)

46 (1–96)

 

41 (4–84)

20 (1–72)

 

38(6–79)

16 (1–62)

 
  1. BCLC stage: Barcelona clinic liver cancer; SR: Surgical resection; HR: Hazard ratio; CI: Conference incidence; HBV: Hepatitis B virus; HCV: Hepatitis C virus; OS: Overall survival; Number (%); Mean or Median (range)